» Articles » PMID: 9723323

Comparative Bioavailability of Neoral and Sandimmune in Cardiac Transplant Recipients over 1 Year

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1998 Sep 2
PMID 9723323
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Development and characterization of dilutable self-microemulsifying premicroemulsion systems (SMEPMS) as templates for preparation of nanosized particulates.

Lin S, Chen Y, Ho H, Huang W, Sheu M, Liu D Int J Nanomedicine. 2013; 8:3455-66.

PMID: 24049445 PMC: 3775676. DOI: 10.2147/IJN.S48465.


Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange.

Singh A, Narsipur S J Transplant. 2011; 2011:480642.

PMID: 22174986 PMC: 3235899. DOI: 10.1155/2011/480642.


In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.

Lin Y, Wu J, Chen Y, Su Y, Ke W, Ho H Int J Nanomedicine. 2011; 6:2445-57.

PMID: 22072880 PMC: 3205139. DOI: 10.2147/IJN.S25339.


Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.

Saint-Marcoux F, Marquet P, Jacqz-Aigrain E, Bernard N, Thiry P, Le Meur Y Clin Pharmacokinet. 2006; 45(9):905-22.

PMID: 16928152 DOI: 10.2165/00003088-200645090-00003.


Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Johnston A, Belitsky P, Frei U, Horvath J, Hoyer P, Helderman J Eur J Clin Pharmacol. 2004; 60(6):389-95.

PMID: 15205865 DOI: 10.1007/s00228-004-0774-8.